🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kartik Sehgal

Brigham and Women's Hospital

ORCID: 0000-0003-4391-6943

Also affiliated with Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 15 papers. Top paper: “Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?”.

Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000697

N/A

2.6DataRank · unranked

50 citations

Andreas Varkaris, Hollis Viray, Paul A. VanderLaan, Deepa Rangachari, Daniel B. Costa +1 more

Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade

Journal of Clinical Investigation(2020)10.1172/jci135038

N/A

1.9DataRank · unranked

75 citations

Andrew Portell, Elena V. Ivanova, Patrick H. Lizotte, Navin R. Mahadevan, Jonathan Greene +23 more

Extrapulmonary manifestations of COVID-19

Nature Medicine(2020)10.1038/s41591-020-0968-3

N/A

1.2DataRank · unranked

3275 citations

Mahesh V. Madhavan, Kartik Sehgal, Nandini Nair, Shiwani Mahajan, Tejasav S. Sehrawat +24 more

Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0590

N/A

0.606DataRank · unranked

56 citations

Michael J. Dennis, Nicole Scarfo, Michelle S. Mullin, Rosh K.V. Sethi, Kartik Sehgal +9 more

Extended-Interval Dosing Strategy of Immune Checkpoint Inhibitors in Lung Cancer: Will it Outlast the COVID-19 Pandemic?

Frontiers in Oncology(2020)10.3389/fonc.2020.01193

N/A

0.470DataRank · unranked

22 citations

Daniel B. Costa, Deepa Rangachari, Kartik Sehgal

Peripheral blood epigenetic immune-profiling and survival outcomes with anti-programmed death (PD)-1 based therapy in recurrent/metastatic (R/M) squamous cell carcinoma of head and neck (SCCHN).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6062

N/A

0.104DataRank · unranked

1 citations

Ze Zhang, Keisuke Shirai, Rondi A. Butler, Min Kyung Lee, Annette M. Molinaro +7 more

Comparison of outcomes with pembrolizumab monotherapy (P) versus combination with chemotherapy (P+C) in advanced non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e21579

N/A

0DataRank · unranked

0 citations

Ritu R. Gill, Poorva Bindal, Anita G. Koshy, Danielle C. McDonald, Deepa Rangachari +2 more

Post-acute COVID-19 syndrome

Nature Medicine(2021)10.1038/s41591-021-01283-z

N/A

0DataRank · unranked

5052 citations

Kartik Sehgal, Aakriti Gupta, Mahesh V. Madhavan, Claire McGroder, Jacob S. Stevens +29 more

Association of Performance Status With Survival in Patients With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy

JAMA Network Open(2021)10.1001/jamanetworkopen.2020.37120

N/A

0DataRank · unranked

165 citations

Ritu R. Gill, Page Widick, Poorva Bindal, Danielle C. McDonald, Meghan Shea +3 more

Additional Oncogenic Alterations in RAS -Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0278

N/A

0DataRank · unranked

27 citations

Sara Ahmadi, Θεοδώρα Παππά, Ellen Marqusee, Kristine Wong, Matthew A. Nehs +8 more

Multifocal, Asymmetric Bilateral Primary Aldosteronism Cannot be Excluded by Strong Adrenal Vein Sampling Lateralization: An International Retrospective Cohort Study

Hypertension(2024)10.1161/hypertensionaha.123.21910

N/A

0DataRank · unranked

52 citations

Yuta Tezuka, Jung Soo Lim, Zara Salman, Kartik Sehgal, Haiping Liu +16 more

Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study

BMJ(2024)10.1136/bmj-2023-077169

N/A

0DataRank · unranked

35 citations

Ilya Glezerman, Jamie S. Hirsch, Kevin L. Chen, Nishant Devaraj, Sophia L. Wells +21 more

A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancer

Cancer Immunology Immunotherapy(2025)10.1007/s00262-025-04271-1

N/A

0DataRank · unranked

0 citations

Kartik Sehgal, Ze Zhang, Rondi A. Butler, John K. Wiencke, Annette M Molinaro +9 more

Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.05.028

N/A

0DataRank · unranked

22 citations

Anushi Bulumulle, Heather Brody, Ritu R. Gill, Shravanti Macherla, Aleksandra Qilleri +10 more

Effect of performance status on survival with pembrolizumab monotherapy in advanced non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9533

N/A

0DataRank · unranked

2 citations

Poorva Bindal, Anita G. Koshy, Ritu Gill, Danielle C. McDonald, Deepa Rangachari +2 more